Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

Background & Aims Patients with chronic hepatitis C virus (HCV) infection and prior null response (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2014-03, Vol.60 (3), p.490-499
Hauptverfasser:	Lok, Anna S, Gardiner, David F, Hézode, Christophe, Lawitz, Eric J, Bourlière, Marc, Everson, Gregory T, Marcellin, Patrick, Rodriguez-Torres, Maribel, Pol, Stanislas, Serfaty, Lawrence, Eley, Timothy, Huang, Shu-Pang, Li, Jianling, Wind-Rotolo, Megan, Yu, Fei, McPhee, Fiona, Grasela, Dennis M, Pasquinelli, Claudio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - administration & dosage Direct-acting antiviral agents Drug Resistance, Viral Drug Therapy, Combination Female Gastroenterology and Hepatology Genotype HCV NS5A inhibitor Hepatitis C treatment Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Imidazoles - administration & dosage Interferon-alpha - administration & dosage Isoquinolines - administration & dosage Male Middle Aged Non-responders Polyethylene Glycols - administration & dosage Protease inhibitor Recombinant Proteins - administration & dosage Ribavirin - administration & dosage Sulfonamides - administration & dosage Sustained virologic response
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background & Aims Patients with chronic hepatitis C virus (HCV) infection and prior null response (
ISSN:	0168-8278 1600-0641
DOI:	10.1016/j.jhep.2013.10.019